MAPK3 and central nervous system cancer: A previous study demonstrated that blocking the RAGE-HMGB1 axis suppresses the growth and metastases of C6 glioma cells by inhibiting the activation of mitogen-activated protein (MAP) kinases, including ERK1/2, p38 and JNK [29].